<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01987154</url>
  </required_header>
  <id_info>
    <org_study_id>6020</org_study_id>
    <nct_id>NCT01987154</nct_id>
  </id_info>
  <brief_title>Tolerance of an Extensively Hydrolyzed Protein Infant Formula Versus a Premature Infant Formula</brief_title>
  <official_title>Tolerance of an Extensively Hydrolyzed Protein Infant Formula Versus a Premature Infant Formula</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mead Johnson Nutrition</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mead Johnson Nutrition</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the use of a hypoallergenic infant formula containing an extensively hydrolyzed
      protein source for routine nutrition.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2014</start_date>
  <completion_date type="Actual">March 2016</completion_date>
  <primary_completion_date type="Actual">March 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Enteral intake (ml/kg/day)</measure>
    <time_frame>Daily for 14 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Body Weight (g)</measure>
    <time_frame>Daily for 14 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Feeding Tolerance</measure>
    <time_frame>Daily for 14 days</time_frame>
    <description>Gastric residuals, regurgitation(&gt;1 ml), fecal output (number of stools per day)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Respiratory status</measure>
    <time_frame>Daily for 14 days</time_frame>
    <description>Apnea and/or bradycardia events, use of supplemental oxygen, use of mechanical ventilation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gut Inflammation</measure>
    <time_frame>Once at Study Day 14</time_frame>
    <description>Fecal calprotectin, alpha and beta defensins, TNF alpha, gastric ultrasound</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Confirmed or suspected sepsis or necrotizing enterocolitis</measure>
    <time_frame>Daily for 14 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Date of hospital discharge</measure>
    <time_frame>Once at hospital discharge</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Growth</measure>
    <time_frame>Study Days 1, 7, and 14</time_frame>
    <description>length (cm) and head circumference (cm)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">61</enrollment>
  <condition>Feeding Intolerance</condition>
  <arm_group>
    <arm_group_label>Marketed cow milk-based premature infant formula</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Marketed extensively hydrolyzed casein infant formula</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Marketed cow milk-based premature infant formula</intervention_name>
    <arm_group_label>Marketed cow milk-based premature infant formula</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Marketed extensively hydrolyzed casein infant formula</intervention_name>
    <arm_group_label>Marketed extensively hydrolyzed casein infant formula</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Premature infant 28 to 33 weeks gestational age, inclusive, at birth

          -  Infant has never received enteral feedings or current enteral intake is less than 30
             mL/kg/day

          -  Birth weight is greater than or equal to 700g to 1750g

          -  Appropriate birth weight for gestational age

          -  Singleton or twin birth

          -  Signed Informed consent

        Exclusion Criteria:

          -  Infant's mother plans to exclusively breast feed

          -  5 minute APGAR score is less than or equal to 4

          -  Major surgery that required general anesthesia prior to randomization

          -  Ventilator-dependent or requiring greater than 40% FiO2 on day of randomization

          -  Grade III or IV intraventricular hemorrhage diagnosed prior to randomization

          -  Infant is currently participating in another clinical study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mariella Baldassarre, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universita degli Studi di Bari</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Azienda Ospedaliera &quot;Ospedale Policlinico Consorziale&quot; di Bari</name>
      <address>
        <city>Bari</city>
        <state>Apulia</state>
        <zip>70124</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>May 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 5, 2013</study_first_submitted>
  <study_first_submitted_qc>November 12, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 19, 2013</study_first_posted>
  <last_update_submitted>May 16, 2016</last_update_submitted>
  <last_update_submitted_qc>May 16, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 17, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Caseins</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

